News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.
Bullfrog Gold Corp (OTCMKTS:BFGC) in its letter to shareholder emphasized that the Company and its flagship Bullfrog Gold Project are substantially stronger and more valuable than they were a year ago, yet BFGC still remains undervalued compared to nearly all peer companies. With the recent increase in trading volume, BFGC seems to be getting attention from investors and traders. Click
HERE to read more.
Shares of Newmont Mining Corporation’s (NYSE:NEM) are up 2.8 percent with a volume of over 2.28M shares as of 11:43 am EST. Recently, the company announced that President and Chief Executive Officer, Gary Goldberg, has signed the World Economic Forum’s (WEF) ‘Compact for Responsive and Responsible Leadership’ on behalf of the Company.
[intr_chart ticker=NEM src=”https://www.journaltranscript.com/wp-content/uploads/2017/02/12601-NEM10.png”]
The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.
Goldcorp Inc. (USA) (NYSE:GG) shares are up 2.94 percent on Thursday morning. Earlier, Auryn Resources Inc. (TSX:AUG.TO)(OTCQX:GGTCF) announced that it has completed the equity placement with Goldcorp Inc. (“Goldcorp”) (TSX:G.TO)(NYSE:GG), as well as the equity placement of flow-through common shares, announced on January 9, 2017.
[intr_chart ticker=GG src=”https://www.journaltranscript.com/wp-content/uploads/2017/02/12601-GG8.png”]
The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend. The market is approaching overbought territory. Be watchful of a trend reversal.
